Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 3:28 pm Sale | 2020-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Bain Capital Life Sciences Fund, L.P. | 1,298,178 3.600% | -49,553 (-3.68%) | Filing History |
| 2021-02-16 3:21 pm Purchase | 2020-12-31 | 13G | Annexon, Inc. ANNX | Bain Capital Life Sciences Fund, L.P. | 2,940,627 7.700% | 2,940,627 (New Position) | Filing History |
| 2021-02-16 3:18 pm Sale | 2020-12-31 | 13G | Constellation Pharmaceuticals, Inc. CNST | Bain Capital Life Sciences Fund, L.P. | 1,270,003 2.700% | -1,291,347 (-50.42%) | Filing History |
| 2021-02-16 3:15 pm Sale | 2020-12-31 | 13G | Replimune Group, Inc. REPL | Bain Capital Life Sciences Fund, L.P. | 0 0.000% | -2,575,360 (Position Closed) | Filing History |
| 2021-02-08 5:00 pm Unchanged | 2021-02-05 | 13D | Arcutis Biotherapeutics, Inc. ARQT | Bain Capital Life Sciences Fund, L.P. | 3,609,796 7.400% | 0 (Unchanged) | Filing History |
| 2020-12-14 5:25 pm Sale | 2020-12-10 | 13D | Dicerna Pharmaceuticals, Inc. DRNA | Bain Capital Life Sciences Fund, L.P. | 2,786,247 3.700% | -904,556 (-24.51%) | Filing History |
| 2020-10-27 4:23 pm Purchase | 2020-10-26 | 13D | Aptinyx Inc. APTX | Bain Capital Life Sciences Fund, L.P. | 8,066,113 13.300% | 3,023,816 (+59.97%) | Filing History |